[Federal Register Volume 63, Number 169 (Tuesday, September 1, 1998)]
[Notices]
[Pages 46458-46461]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 98-23476]



[[Page 46458]]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Diseases Control and Prevention


Statement of Organization, Functions, and Delegations of 
Authority

    Part C (Centers for Diseases Control and Prevention) of the 
Statement of Organization, Functions, and Delegations of Authority of 
the Department of Health and Human Services (45 FR 67772-76, dated 
October 14, 1980, and corrected at 45 FR 69296, October 20, 1980, as 
amended most recently at 63 FR 34408-09, dated July 16, 1998) is 
amended to reflect the restructuring of the Division of HIV/AIDS 
Prevention, National Center for HIV, STD, and TB Prevention, Centers 
for Diseases Control and Prevention.
    Section C-B, Organization and Functions, is hereby amended as 
follows:
    Retitle the Division of HIV/AIDS Prevention (CK2) to the Division 
of HIV/AIDS Prevention--Intervention Research and Support (CK2). Delete 
the functional statement and insert the following:
    (1) In cooperation with the CDC components, administers operational 
programs for the prevention of human immunodeficiency virus (HIV) 
infection and acquired immunodeficiency syndrome (AIDS); (2) provides 
consultation, training, promotional, educational, other technical 
services to assist State and local health departments, as well as 
national, State, and local nongovernmental organizations, in the 
planning, development, implementation, evaluation and overall 
improvement of HIV prevention programs; (3) conducts behavioral, 
communications, evaluation, and operational research into factors 
affecting the prevention of HIV/AIDS; (4) develops recommendations and 
guidelines on the prevention of HIV/AIDS; (5) evaluates prevention and 
control activities in collaboration with other CDC components; (6) 
provides assistance and consultation on issues related to programmatic 
support, research, evaluation methodologies, and fiscal and grants 
management to State and local health departments, nongovernmental 
organizations, national organizations, and other research institutions; 
(7) promotes linkages between health department HIV/AIDS programs and 
other governmental and nongovernmental partners who are vital to 
effective HIV/AIDS prevention efforts; (8) works closely with Health 
Care Financing Administration (HCFA), Health Resources and Services 
Administration (HRSA), other governmental and nongovernmental agencies, 
and the managed care community (or the private medical sector) to 
enhance and evaluate HIV prevention services in public and private 
health care delivery systems; (9) provides consultation to other Public 
Health Service agencies, medical institutions, private physicians, and 
international organizations or agencies; (10) provides information to 
the scientific community and the general public through publications 
and presentations; (11) implements national HIV/AIDS prevention public 
information programs and assists in developing strategic communications 
activities and services at the national level to inform and educate the 
American public about HIV/AIDS, especially people whose behavior places 
them at risk for HIV infection; (12) provides technical support to CDC 
assignees to State and local health departments who are working on HIV/
AIDS prevention and communications activities.
    Delete the functional statement for the Office of the Director 
(CK21) and insert the following:
    (1) Plans, directs, and evaluates the activities of the division; 
(2) develops goals and objective and provides national leadership and 
guidance in HIV/AIDS prevention policy formulation and program planning 
and development; (3) provides leadership for developing research in 
behavioral aspects of HIV/AIDS prevention, evaluation of HIV/AIDS 
prevention, and in coordinating activities between the division and 
other NCHSTP divisions, CDC Centers, Institute, and Program Offices 
(CIOs), and national-level prevention partners who influence HIV/AIDS 
prevention programs involved in HIV/AIDS investigations, research, and 
prevention activities; (4) in collaboration with other components of 
CDC and with other governmental and non-governmental organizations, 
develop and promotes policies and evaluation methods and recommends 
research to enhance HIV prevention and control efforts in public and 
private health care delivery systems; (5) provides oversight for human 
subjects review of protocols and coordinates human subjects review 
training; (6) coordinates within the division and between the division 
and the Communications Office, NCHSTP, the response to the national and 
local communications media on HIV/AIDS issues; (7) ensures 
multidisciplinary collaboration in HIV/AIDS prevention activities; (8) 
provides leadership and guidance for program management and operations 
and the development of training and educational programs; (9) 
coordinates the development of guidelines and standards to ensure 
ongoing, effective HIV prevention programs and their evaluations; (10) 
oversees the creation of materials designed for use by the media, 
including press releases, letters to the editor, and other print and 
electronic materials and programs, and ensures appropriate clearance of 
these materials; (11) assists in the preparation of speeches and 
Congressional testimony on HIV/AIDS for the Division Director, the 
Center Director, and other public health officials; (12) provides 
program services support in extramural programs management, 
administrative services, and information systems services; (13) 
collaborates, as appropriate, with nongovernmental organizations to 
achieve the mission of the division; (14) provides international 
consultation in collaboration with the Division of HIV/AIDS 
Prevention--Surveillance and Epidemiology's lead activity on 
international HIV/AIDS activities; (15) collaborates with other 
branches, divisions, and CIOs to synthesize HIV prevention practices; 
(16) in carrying out these activities, collaborates, as appropriate, 
with other divisions and offices of NCHSTP, and with other CIOs 
throughout CDC.
    Delete the title and functional statement for the International 
Activity (CK211).
    Delete the title and functional statement for the Technical 
Information Activity (CK212).
    Delete the functional statement for the Behavioral Intervention 
Research Branch (CK22) and insert the following:
    (1) Applies current theory, practice, and empirical findings in 
designing and conducting research on state-of-the-art interventions to 
prevent HIV infection; (2) conducts research to examine methodological 
issues related to implementation, design and evaluation aspects of 
behavioral intervention research trials; (3) conducts research to 
examine the processes and factors that influence effective and 
efficient translation, diffusion, and sustainability of behavioral 
intervention research findings to HIV prevention programs; (4) 
summarizes and synthesizes the intervention research literature to 
derive research priorities and specify the characteristics of effective 
interventions to prevent HIV infection; (5) contributes to the 
intervention research literature by publishing regularly in peer-
reviewed journals and CDC-sponsored publications; (6) collaborates with

[[Page 46459]]

Federal, State, and local HIV prevention partners in identifying 
research priorities and in designing intervention research (7) 
collaborates and consults with CDC staff, other Public Health Service 
agencies, State and local health departments, and other groups and 
organizations involved in HIV prevention activities to devise and 
facilitate technical assistance systems and activities related to the 
application of behavioral science research findings to prevention 
programs and policies.
    Delete the functional statement for the Community Assistance, 
Planning, and National Partnerships Branch (CK23) and insert the 
following:
    (1) In collaboration with State and local public health and non-
governmental national/regional and local partners, CDC CIOs, and other 
Federal agencies, develops and implements programs, policies, and 
activities that enable and mobilize affiliates and communities to 
become involved with, and support, local and statewide strategic 
community planning that improves HIV prevention programs and 
activities; (2) plans, develops, implements, and manages strategies and 
resources that build a comprehensive public health private-sector 
partnership to prevent HIV infection/AIDS; (3) provides technical 
consultation and assistance to State and local health departments, 
community planning groups,and nongovernmental and other prevention 
partners in operational aspects of HIV prevention; (4) monitors 
activities of HIV prevention projects to ensure operational objectives 
are being met; (5) establishes guidelines and policies for 
implementation and continuation of State and local HIV prevention 
programs; (6) provides technical review of grant applications and 
prevention plans; (7) conducts continuing analysis of support 
utilization and career development of field personnel and analysis of 
other resource allocations and utilization in relation to HIV 
prevention; (8) provides supervision for HIV prevention field staff; 
(9) assists in the development of new operational programs and program 
solicitations for HIV prevention; (10) coordinates program development 
and implementation with State/local/regional community planning groups; 
(11) facilitates linkages with sexually transmitted diseases (STDs) and 
other HIV prevention programs at all levels to ensure coordination of 
harm reduction and intervention strategies for populations with common 
prevention needs; (12) works with national partners to foster HIV 
prevention capabilities and activities in affected communities; (13) 
funds and monitors the progress of minority and other community-based 
organizations undertaking HIV prevention programs and activities; (14) 
develops national public information programs for HIV/AIDS prevention, 
working closely with behavioral scientists to create communications 
messages that effectively promote adoption or maintenance of safe 
behaviors; (15) promotes and facilitates the application of social 
marketing principles to HIV prevention at the State and local levels; 
(16) collaborates with external organizations and the news, public 
service, entertainment, and other media to ensure that effective 
prevention messages reach the public; (17) in collaboration with the 
Training and Technical Support Systems Branch, creates and disseminates 
materials that incorporate prevention marketing principles for use at 
national, State, and local levels.
    Delete the title and functional statement for the Edipdemiology 
Branch (CK24). 
    Delete the title and functional statement for the HIV/AIDS 
Surveillance Branch (CK25).
    Delete the title and functional statement for the HIV 
Seroepidemiology Branch (CK26).
    Delete the title and functional statement for the Prevention 
Communications Branch (CK27).
    Retitle the Program Evaluation Branch (CK28) to the Program 
Evaluation Research Branch (CK28). 
    Delete the title and functional statement for the Statistics and 
Data Management Branch (CK29). 
    After the functional statement for the Training and Technical 
Support Systems Branch (CK2A), insert the following:
    Techical Information and Communications Branch (CK2B). (1) 
Evaluates the effectiveness, costs, and impact of HIV prevention 
interventions, strategies, policies, and programs as practiced or 
implemented by public health agencies and organizations at the 
national/regional and State/local levels; (2) collaborates in the 
application of evaluation findings and techniques to the ongoing 
assessment and improvement of HIV prevention programs; (3) conducts 
evaluation research activities that include studies to evaluate the 
effectiveness and impact of prevention strategies and programs, major 
prevention activities, and policies; economic evaluations of HIV 
prevention, including assessments of alternative prevention strategies 
to encourage the best use of prevention resources; and development of 
both process and outcome measures that HIV prevention programs can use 
to assess their going performance; (4) seeks to advance the methodology 
of HIV prevention evaluation through evaluation research activities; 
(5) applies evaluation methods to improving HIV prevention programs, 
including serving as a resource to other branches/activities, grantees, 
and prevention partners regarding evaluation of both domestic and 
international HIV prevention programs; collaborating with other 
branches as they develop, test, and disseminate models for quality 
assurance of programs and services; and collaborating with other 
branches/activities in the development of methods to support the 
systematic assessment (including self-assessment) and continuous 
improvement of HIV prevention programs.
    After the title and functional statement for the Surveillance and 
Epidemiology Branch (CK46), Division of Tuberculosis Elimination (CK4), 
insert the following:
    Division of HIV/AIDS Prevention--Surveillance and Epidemiology 
(CK5). (1) Conducts national surveillance of the human immunodeficiency 
virus/acquired immunodeficiency syndrome (HIV/AIDS); (2) provides 
consultation and statistical, epidemiological, and other technical 
services to assist State and local health departments, as well as 
national, State, and local nongovernmental organizations, in the 
planning, development, implementation, and overall improvement of HIV 
prevention programs; (3) conducts epidemiologic, surveillance, 
etiologic, health services and operational research into factors 
affecting the prevention of HIV/AIDS; (4) develops recommendations and 
guidelines on the prevention of HIV/AIDS and associated illnesses; (5) 
monitors surveillance of risk behaviors associated with HIV 
transmission; (7) determines risk factors and transmission patterns of 
HIV/AIDS by conducting national and international HIV/AIDS 
surveillance, epidemiologic investigations, and research studies; (8) 
develops preventive health services models for a variety of HIV-related 
activities; (9) provides assistance and consultation on issues related 
to epidemiology, surveillance, and research to NCHSTP, CDC, other 
Public Health Service agencies, State and local health agencies, 
community-based organizations; CDC prevention partners, medical 
institutions, private physicians, and international organizations; (10) 
provides epidemic aid, epidemiologic and surveillance consultation, and 
financial assistance for HIV/AIDS surveillance activities to State and 
local

[[Page 46460]]

health departments; (11) provides information on HIV/AIDS surveillance 
and epidemiology to the scientific community and the general public 
through publications and presentations; (12) works closely with 
National Center for Infectious Diseases (NCID) on HIV/AIDS surveillance 
and epidemiologic investigations that require laboratory collaboration, 
and on activities related to the investigation and prevention of HIV-
related opportunistic infections; (13) provide technical support to CDC 
assignees to State and local health departments who are working on HIV/
AIDS surveillance activities; and (14) serves as the World Health 
Organization (WHO) Collaborating Division on HIV/AIDS for epidemiology 
and surveillance.
    Office of the Director (CK51). (1) Plans, directs, and evaluates 
the activities of the division; (2) develops goals and objectives and 
provides national leadership and guidance in HIV/AIDS prevention policy 
formulation and program planning and development; (3) provides 
leadership in developing research in epidemiology, surveillance, and 
other scientific aspects of HIV/AIDS prevention, and in coordinating 
activities between the division and other NCHSTP divisions, CDC CIOs, 
and national-level prevention partners who influence HIV/AIDS 
prevention programs involved in HIV/AIDS investigations and research; 
(4) provides oversight for human subjects review of protocols and 
coordinates human subjects review training; (5) maintains lead 
responsibility for HIV/AIDS issues related to epidemiology, 
surveillance, or policy; (6) provides leadership and guidance for the 
development of data management systems; (7) assists in the preparation 
of speeches and Congressional testimony on HIV/AIDS for the division 
Director, the Center Director, and other public health officials; (8) 
coordinates international HIV/AIDS activities of the division and 
ensures interdivisional coordination of international activists within 
the center and CDC, as appropriate; (9) provides program services 
support in extramrual programs management, administrative services, and 
information systems services; (10) collaborates, as appropriate, with 
nongovernmental organizations to achieve the mission of the division; 
and (11) in carrying out these activities, collaborates, as 
appropriate, with other divisions and offices of NCHSTP, and with other 
CIOs throughout CDC.
    Epidemiology Branch (CK52). (1) Designs and conducts epidemiologic 
and behavioral studies in the United States to determine risk factors, 
co-factors, and modes of transmission for HIV infection and AIDS; (2) 
conducts studies of the natural history of HIV infection, including 
manifestations of HIV disease in adults, adolescents, and children; (3) 
designs and conducts research on the psychosocial, cultural and 
contextual determinants of risk behaviors related to HIV risk 
behaviors; (4) describes psychosocial impact of HIV on infected 
individuals, their families, and close contacts and identifies 
psychosocial and cultural determinants of disease outcomes of HIV-
infected individuals; (5) conducts both epidemiologic and behavioral 
studies to evaluate appropriate biomedical interventions for preventing 
HIV infection (primary prevention) and for preventing manifestations of 
AIDS (secondary prevention); (6) conducts applied research, including 
effectiveness trials, to assist in evaluation of strategies, major 
activities, and policies; (7) conducts epidemic aid investigations of 
HIV infection and associated infectious diseases, as well as other 
illnesses related to HIV/AIDS; (8) develops policy related to both 
primary prevention of HIV infection and secondary prevention of its 
severe manifestations based on scientific investigations and clinical 
trials; (9) provides epidemiologic consultation to State and local 
health departments, other Public Health Service agencies, universities, 
and other groups and individuals investigating HIV/AIDS; (10) responds 
to inquiries from physicians and other health providers for information 
on the medical and epidemiologic aspects of HIV/AIDS; (11) collaborates 
internationally with HIV/AIDS researchers and the International 
Activities Branch in the conduct of epidemiologic studies; and (12) 
works closely with NCID to determine virologic and immunologic factors 
related to transmission and natural history of HIV infection.
    Internatioal Activities Branch (CK53). (1) Designs and executes 
epidemiologic and interventional studies of HIV infection and its 
associated illnesses in other Nations; (2) develops and conducts 
epidemiologic studies of risk factors for AIDS and HIV transmission in 
other Nations; (3) assists in the design, implementation, and 
evaluation of AIDS prevention and control activities; (4) manages 
international field sites and staff assigned to those sites; (5) in 
collaboration with NCID, conducts international surveillance and 
studies of HIV genotypic variants and their epidemiologic and 
diagnostic implications; (6) provides technical assistance to other 
Nations to develop AIDS case surveillance systems; (7) assists foreign 
governments in carrying out seroprevalance studies and surveys; (8) 
collaborates with other branches in assisting developing countries in 
the design, implementation, and evaluation of strategies to protect 
their blood supplies; (9) coordinates with other CIOs in CDC that have 
similar international responsibilities; (10) provides consultation to 
WHO, USAID, and other organizations whose mission is to prevent and 
control HIV infection and related outcomes; (11) collaborates with 
national and international organizations to strengthen public health 
infrastructures at national levels, contributing to technical and 
managerial sustainability of national HIV prevention and control 
programs; (12) assist national and international organizations in 
identifying, developing, and promoting HIV interventions an 
technologies that are feasible, effective, and culturally appropriate 
for use in developing countries.
    Prevention Services Research Branch (CK54). (1) Plans, develops, 
and conducts research to develop and improve HIV preventions strategies 
and service provision; (2) plans, develops, and coordinates local and 
regional studies of the determinants of risk for HIV infection in 
specific populations; (3) plans, develops, and coordinates local and 
regional studies to identify and evaluate specific at-risk populations, 
and examines and evaluates prevention service application in these 
populations; (4) collaborates closely with other NCHSTP and CDC 
organizations in applying research methods to target, evaluate, and 
monitor HIV prevention programs in specific geographic settings and at-
risk populations; (5) develops and utilizes specific research 
evaluation and monitoring methodologies including prevalence and 
incidence studies of HIV and related infections in selected geographic 
areas and at-risk populations; (6) collects data on the extent of HIV 
prevalence and incidence in the United States; (7) collaborates with 
division staff to evaluate HIV/AIDS trends in incidence and prevalence; 
(8) serves as a focus for national and international activities related 
to transfusion-related HIV transmission; (9) develops, plans, and 
conducts studies of HIV counseling and testing activities in a variety 
of prevention service settings, including but not limited to publicly 
funded managed care settings; (10) collects and analyzes HIV prevalence 
and incidence date from publicly funded HIV counseling and

[[Page 46461]]

testing sites; (11) assists NCID with the evaluation of new HIV-related 
tests; (12) conducts local and regional studies of HIV genotypic 
variations and antiretroviral drug resistance; (13) collaborates with 
NCID laboratories to develop a repository of stored sera and cells for 
studies of HIV and related infections.
    Statistics and Data Management Branch (CK55). (1) Manages, directs, 
and coordinates the statistics and data management activities and 
services for the division and the Division of HIV/AIDS Prevention--
Intervention Research and Support (DHAP/IRS); (2) provided leadership 
in the development of statistical and data management planning, policy, 
implementation, and evaluation; (3) provides data management and 
statistical support for HIV/AIDS surveillance, HIV serosuryveys, 
epidemiologic studies and other studies conducted within the division 
and DHAP/IRS; (4) creates mathematical models to project the incidence 
of AIDS and HIV infection; (5) develops, monitors, and evaluate 
projects to construct mathematical models of the spread of AIDS and HIV 
infection and other HIV and AIDS studies; (6) provides statistical 
models of epidemiologic parameters to describe the efficiency of HIV 
transmission and the incubation time for AIDS; (7) responds to 
inquiries from medical professionals, health departments, the media, 
and the public about AIDS epidemic statistical issues, including 
projections of the number of AIDS cases and estimates of person 
infected with HIV; (8) coordinates contracted programming services for 
the division.
    Surveillance Branch (CK56). (1) Conducts surveillance of HIV 
infection and AIDS in coordination with State and local health 
departments to provide population-based data for public health policy 
development and evaluation; (2) maintains, analyzes, and disseminates 
information from the national confidential registry of HIV/AIDS cases; 
(3) monitors HIV-related morbidity and mortality and the use of 
recommendations for prevention and treatment of HIV infection and AIDS; 
(4) promotes uses of surveillance data for prevention and evaluation; 
(5) conducts surveillance of special populations of epidemiologic 
importance, e.g., persons with HIV-2 infection, health care workers for 
occupationally related HIV transmission, and person reported with 
unrecognized modes of transmission; (6) in coordination with State and 
local health departments, conducts population-based surveillance of 
HIV-related risk behaviors; (7) assesses socioeconomic, educational, 
and other factors of use in targeting and evaluating prevention and 
care programs; (8) evaluates surveillance systems for HIV infection and 
AIDS and modifies surveillance methodologies as needed to meet changing 
needs of HIV/AIDS programs; (9) manages extramural funding of 
surveillance activities and provides consultations and technical 
assistance on surveillance activities and methodologies to State and 
local health departments and national and international organizations 
and agencies.

    Dated: August 24, 1998.
Stephen B. Thacker,
Acting Deputy Director, Centers for Disease Control and Prevention.
[FR Doc. 98-23476 Filed 8-31-98; 8:45am]
BILLING CODE 4160-18-M